- Home
- LMAT vs EVT Comparison
LMAT vs EVT Comparison
Compare LMAT & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMAT
- EVT
- Stock Information
- Founded
- LMAT 1983
- EVT 2003
- Country
- LMAT United States
- EVT United States
- Employees
- LMAT N/A
- EVT N/A
- Industry
- LMAT Medical/Dental Instruments
- EVT Finance Companies
- Sector
- LMAT Health Care
- EVT Finance
- Exchange
- LMAT Nasdaq
- EVT Nasdaq
- Market Cap
- LMAT 1.9B
- EVT 1.9B
- IPO Year
- LMAT 2006
- EVT N/A
- Fundamental
- Price
- LMAT $93.42
- EVT $24.40
- Analyst Decision
- LMAT Buy
- EVT
- Analyst Count
- LMAT 6
- EVT 0
- Target Price
- LMAT $99.67
- EVT N/A
- AVG Volume (30 Days)
- LMAT 162.2K
- EVT 115.5K
- Earning Date
- LMAT 10-30-2025
- EVT 01-01-0001
- Dividend Yield
- LMAT 0.86%
- EVT 8.32%
- EPS Growth
- LMAT 22.69
- EVT N/A
- EPS
- LMAT 2.05
- EVT 6.63
- Revenue
- LMAT $234,639,000.00
- EVT $69,404,302.00
- Revenue This Year
- LMAT $16.32
- EVT N/A
- Revenue Next Year
- LMAT $8.62
- EVT N/A
- P/E Ratio
- LMAT $45.17
- EVT $3.55
- Revenue Growth
- LMAT 14.11
- EVT N/A
- 52 Week Low
- LMAT $71.42
- EVT $19.20
- 52 Week High
- LMAT $109.58
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- LMAT 50.38
- EVT 56.45
- Support Level
- LMAT $91.24
- EVT $24.23
- Resistance Level
- LMAT $93.93
- EVT $24.60
- Average True Range (ATR)
- LMAT 2.74
- EVT 0.21
- MACD
- LMAT -0.75
- EVT -0.02
- Stochastic Oscillator
- LMAT 38.78
- EVT 62.26
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.